Psychiatry AdvisorClozapine, Amisulpride, Olanzapine, Risperidone Most Effective For Schizophrenia

A network meta-analysis pooling 78,193 patients across RCTs of 24 antipsychotics found small-to-medium efficacy differences favoring clozapine, amisulpride, olanzapine, and risperidone. Authors call for guidelines to reflect these distinctions in individualized care.

Clinical Considerations

• Clozapine produced the largest overall symptom reduction (SMD -0.90), followed by sulpiride and amisulpride across pooled RCTs
• Perospirone, clozapine, and zotepine led for negative symptoms; xanomeline-trospium ranked third for positive symptom reduction
• Tolerability diverged sharply: clozapine drove sedation (OR 6.37), haloperidol drove anti-Parkinson drug use, and zotepine drove weight gain
• Xanomeline-trospium, the first non-dopamine-centric agent, avoided dopamine-blocking effects but produced cholinergic adverse events (OR 4.11)

Practice Applications

• Consider efficacy ranking alongside individual tolerability needs when selecting an antipsychotic
• Recognize clozapine’s efficacy advantage despite its sedation and monitoring burden
• Monitor weight, prolactin, QTc, and extrapyramidal symptoms based on the agent prescribed
• Interpret xanomeline-trospium as a distinct mechanistic option with its own cholinergic profile

More in Schizophrenia